Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers


  Free Subscription


1 Am J Gastroenterol
1 Arch Virol
1 Dig Dis Sci
2 Gastroenterology
1 Gut
6 Hepatology
1 J Clin Gastroenterol
1 J Clin Microbiol
1 J Hepatol
1 J Med Virol
2 J Viral Hepat
3 PLoS One
1 Proc Natl Acad Sci U S A
2 Vaccine

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles


  1. FRANCO S, Buccione D, Tural C, Martinez MA, et al
    Circulating microRNA signatures that predict liver fibrosis progression in patients with HIV-1/HCV co-infections.
    AIDS. 2021 Mar 31. pii: 00002030-900000000-96441.
    PubMed         Abstract available

    Am J Gastroenterol

  2. TAN HK, Teng MLP, Soh AYS, Cheo SHY, et al
    Poor Outcomes of Cirrhosis due to Nonalcoholic Steatohepatitis Compared With Hepatitis B After Decompensation With Ascites.
    Am J Gastroenterol. 2021 Feb 1. doi: 10.14309/ajg.0000000000001176.
    PubMed         Abstract available

    Arch Virol

  3. ALI NA, Hamdy NM, Gibriel AA, El Mesallamy HO, et al
    Investigation of the relationship between CTLA4 and the tumor suppressor RASSF1A and the possible mediating role of STAT4 in a cohort of Egyptian patients infected with hepatitis C virus with and without hepatocellular carcinoma.
    Arch Virol. 2021 Apr 1. pii: 10.1007/s00705-021-04981.
    PubMed         Abstract available

    Dig Dis Sci

    Immune Inhibitory Properties and Therapeutic Prospects of Transforming Growth Factor-Beta and Interleukin 10 in Autoimmune Hepatitis.
    Dig Dis Sci. 2021 Apr 9. pii: 10.1007/s10620-021-06968.
    PubMed         Abstract available


  5. ZOULIM F, Lenz O, Vandenbossche JJ, Talloen W, et al
    JNJ-56136379, an HBV Capsid Assembly Modulator, Is Well-Tolerated and Has Antiviral Activity in a Phase 1 Study of Patients With Chronic Infection.
    Gastroenterology. 2020;159:521-533.
    PubMed         Abstract available

  6. CHENG CY, Wu J
    Erythematous plaques on legs and feet in a patient with hepatitis C.
    Gastroenterology. 2021 Apr 1. pii: S0016-5085(21)00587.


  7. PHAM LV, Pedersen MS, Fahnoe U, Fernandez-Antunez C, et al
    HCV genome-wide analysis for development of efficient culture systems and unravelling of antiviral resistance in genotype 4.
    Gut. 2021 Apr 8. pii: gutjnl-2020-323585. doi: 10.1136/gutjnl-2020-323585.
    PubMed         Abstract available


  8. KAPILA N, Rahman AU, Zervos XB
    Hepatology. 2020;72:788.

    Is It Time to Consider Gut Microbiome Readouts for Precision Diagnosis and Treatment of Alcoholic Liver Disease?
    Hepatology. 2020;72:4-6.

  10. ZHAO Q, Guo JT
    Have the Starting Lineup of Five for Hepatitis B Virus Covalently Closed Circular DNA Synthesis Been Identified?
    Hepatology. 2020;72:1142-1144.

  11. JONAS MM, Rhee S, Kelly DA, Del Valle-Segarra A, et al
    Pharmacokinetics, safety, and efficacy of glecaprevir/pibrentasvir in children with chronic hepatitis C virus: part 2 of the DORA study.
    Hepatology. 2021 Apr 2. doi: 10.1002/hep.31841.
    PubMed         Abstract available

  12. LEE YB, Lee J
    Letter to the Editor: Use of New Defined Metabolic Risk Factors in Patients with Chronic Hepatitis B - The Authors' reply.
    Hepatology. 2021 Apr 2. doi: 10.1002/hep.31844.
    PubMed         Abstract available

  13. LIU Y, Wang S, Hu L
    Letter to the Editor: Use of New Defined Metabolic Risk Factors in Patients with Chronic Hepatitis B.
    Hepatology. 2021 Apr 8. doi: 10.1002/hep.31842.
    PubMed         Abstract available

    J Clin Gastroenterol

  14. WANG Y, Han SB
    Hepatitis B Reactivation: A Review of Clinical Guidelines.
    J Clin Gastroenterol. 2021;55:393-399.
    PubMed         Abstract available

    J Clin Microbiol

  15. LIN N, Ye A, Lin J, Liu C, et al
    Diagnostic Value of Detection of Pregenomic RNA in Sera of Hepatitis B Virus-Infected Patients with Different Clinical Outcomes.
    J Clin Microbiol. 2020;58.
    PubMed         Abstract available

    J Hepatol

    Hepatitis B virus - an anaerobic organism?
    J Hepatol. 2021 Apr 2. pii: S0168-8278(21)00166.

    J Med Virol

  17. BULFONI M, Pravisani R, Dalla E, Cesselli D, et al
    miRNA expression profiles in liver grafts of HCV and HIV/HCV infected recipients, six months after liver transplantation.
    J Med Virol. 2021 Apr 5. doi: 10.1002/jmv.26999.
    PubMed         Abstract available

    J Viral Hepat

  18. DZINGIRAI B, Katsidzira L, Matyanga CMJ, Postma MJ, et al
    Progress on the elimination of viral hepatitis in Zimbabwe: A review of the policies, strategies and challenges.
    J Viral Hepat. 2021 Apr 2. doi: 10.1111/jvh.13510.
    PubMed         Abstract available

  19. YAO K, Liu J, Wang J, Yan X, et al
    Distribution and clinical characteristics of patients with chronic hepatitis B virus infection in the gray zone.
    J Viral Hepat. 2021 Apr 2. doi: 10.1111/jvh.13511.
    PubMed         Abstract available

    PLoS One

  20. MIRZAZADEH A, Chen YH, Lin J, Burk K, et al
    Progress toward closing gaps in the hepatitis C virus cascade of care for people who inject drugs in San Francisco.
    PLoS One. 2021;16:e0249585.
    PubMed         Abstract available

  21. Correction: Seroepidemiology of hepatitis A, B, C, D and E virus infections in the general population of Peru: A cross-sectional study.
    PLoS One. 2021;16:e0250185.
    PubMed         Abstract available

  22. TONEN-WOLYEC S, Djang'eing'a RM, Batina-Agasa S, Kayembe Tshilumba C, et al
    Self-testing for HIV, HBV, and HCV using finger-stick whole-blood multiplex immunochromatographic rapid test: A pilot feasibility study in sub-Saharan Africa.
    PLoS One. 2021;16:e0249701.
    PubMed         Abstract available

    Proc Natl Acad Sci U S A

  23. LOPEZ ANGEL CJ, Pham EA, Du H, Vallania F, et al
    Signatures of immune dysfunction in HIV and HCV infection share features with chronic inflammation in aging and persist after viral reduction or elimination.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed         Abstract available


  24. ZAHN T, Akhras S, Spengler C, Murra RO, et al
    A new approach for therapeutic vaccination against chronic HBV infections.
    Vaccine. 2020 Feb 26. pii: S0264-410X(20)30291.
    PubMed         Abstract available

  25. YAO T, Shao Z, Wu L, Dong S, et al
    Long-term persistent immunogenicity after successful standard and triple-dosed hepatitis B vaccine in hemodialysis patients: A 3-year follow-up study in China.
    Vaccine. 2021 Apr 2. pii: S0264-410X(21)00378.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Hepatitis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.